Protagonist Therapeutics Inc Forecast and Target Price
$42.95
Protagonist Therapeutics Inc (PTGX) Share Price Forecast
Currently 12 wall-street analysts regularly analyze the financials of Protagonist Therapeutics Inc on a frequent basis to provide recommendations along with target share price. 12 analysts offering 12-month price forecasts for Protagonist Therapeutics Inc (PTGX) have a share price target of $69.1. This median of share price forecast represents a 60.88% upside from the latest price of $42.95 as on 11.05.25.
Protagonist Therapeutics Inc (PTGX) Price vs Consensus Price Target
As per the chart shown above, analysts believe that the Protagonist Therapeutics Inc (PTGX) share price will touch around $69.1 in next 12-months.
Protagonist Therapeutics Inc (PTGX) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Protagonist Therapeutics Inc's share price and its median forecast price. As on 11.05.25, the difference is -34.89%
Protagonist Therapeutics Inc (PTGX): Difference between Current Price & Median Forecasted Price
Protagonist Therapeutics Inc (PTGX) Share Price : Analyst Recommendation
Based on 12 analysts tracking and researching Protagonist Therapeutics Inc (PTGX) share have buy recommendation on an average.
| 3M Ago | 1M Ago | Current | |
| Buy | 7 | 7 | 7 |
| Outperform | 4 | 4 | 4 |
| Hold | 1 | 1 | 1 |
| Underperform | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |